The Ocular Gene Therapy Core at the Bethesda, Maryland campus of National Eye Institute (NEI), National Institutes of Health (NIH), has an opening for a postdoctoral fellow. A major focus of research is the development of ocular gene therapeutics based on AAV vectors and CRISPR genome editing techniques. Our major disease targets are X-linked retinoschisis, retinitis pigmentosa, and Leber congenital amaurosis. The successful candidate will also be involved in transitioning successful vectors to clinical trials at the NEI Clinical Center. For more information of our research, please go to https://nei.nih.gov/intramural/ocular_gene. Applicants should have a strong background in molecular biology and extensive experience with animal models of human diseases. AAV vector/gene therapy or genome editing experience is desirable but not essential. The position provides generous scientific resources and stipend support. Applicants must have a Ph.D. and/or M.D. U.S. citizens, U.S. permanent residents, and non-U.S. citizens are eligible to apply.
To apply, please send a curriculum vitae, bibliography, and three letters of reference via e-mail or post to: